The Company’s focus is on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. IntelGenx’ business strategy is to develop pharmaceutical products based on the Company’s proprietary drug delivery technologies and, once the viability of a product has been demonstrated, to license the commercial rights to partners in the pharmaceutical industry.The company is currently developing products for multiple indications including for the treatment of severe depression, osteoarthritis, hypertension, erectile dysfunction and pain management.